Skip to content

Clinical study on the safety and efficacy of iliac vein stent system in the treatment of iliac vein stenosis or occlusion

Clinical study on the safety and efficacy of iliac vein stent system in the treatment of iliac vein stenosis or occlusion

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057851
Enrollment
Unknown
Registered
2022-03-19
Start date
2019-02-01
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iliac vein compression syndrome

Interventions

test group:the new iliac vein stent
control group :the zilver vena stent

Sponsors

First Affiliated Hospital of USTC(Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 18 = 75; Gender is not limited; 2. Iliac vein stenosis: = 50% (DSA or CTV); 3. Clinical classification of CEAP: = C3; 4. Subjects or their legal guardians can understand the purpose of the trial, are willing to cooperate with interventional surgery and follow-up, voluntarily participate in the trial and sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with previous interventional surgery in target iliac vein; 2.Iliac vein stenosis caused by pelvic tumor compression, previous radiotherapy, post-thrombotic syndrome (medical history and doppler ultrasound examination)iliac vein stenosis after catheterization thrombolysis or thrombectomy due to DVT within half a year; 3.Contraindicated to contrast agent or anticoagulant drugs; 4.Severe abnormal blood coagulation; 5.Severe hepatic and/or renal insufficiency; 6.Life expectancy less than 12 months; 7.Iliac vein size not applicable to vein stent; 8.History of allergy to materials (nickel titanium and tantalum; 9.Men or women who plan to have children during pregnancy, lactation or within 12 months; 10.Patients who has participated in, is participating in, or plans to participate in any other device or drug clinical trial within 3 months prior to screening; 11.Patients considered unsuitable for this clinical trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Patency rate of iliac vein 12 months after operation;

Secondary

MeasureTime frame
Success rate and defect rate of the stent;Minimum lumen diameter and diameter stenosis of iliac vein 12 months after surgery;Surgical success rate;Changes in venous clinical severity (VCSS) scores at 3 and 12 months postoperatively;CEAP grading was performed 3 and 12 months after surgery;

Countries

China

Contacts

Public ContactHeJie Hu

First Affiliated Hospital of USTC(Anhui Provincial Hospital)

342173670@qq.com+86 13956007036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026